SCHEMBL5668902

SCHEMBL5668902

CSc1ccccc1CNC(=O)c1coc(CNC(=O)COc2ccc(OC(F)(F)F)cc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CACNA1G O43497 1/20 0.44
CACNA1H O95180 1/20 0.44
CACNA1I Q9P0X4 1/20 0.44
SCN10A Q9Y5Y9 4/20 0.43
SCN2A Q99250 3/20 0.43
SMN1; SMN2 Q16637 3/20 0.39
HTT P42858 2/20 0.39
PKM P14618 2/20 0.39
NPC1 O15118 1/20 0.39
TAOK1 Q7L7X3 1/20 0.38
TAOK3 Q9H2K8 1/20 0.38
MCHR1 Q99705 1/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
HPGD P15428 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
TSHR P16473 1/20 0.36
ALDH1A1 P00352 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2171264 0.87 NPC1 (0.55) CACNA1GCACNA1HCACNA1ISCN10ASCN2A
SCHEMBL4388997 0.87 CACNA1G (0.46) CACNA1GCACNA1HCACNA1ISCN10ASCN2A
SCHEMBL2173835 0.84 NPC1 (0.46) CACNA1GCACNA1HCACNA1ISCN10ASCN2A
SCHEMBL2171492 0.83 TRPV1 (0.56) CACNA1GCACNA1HCACNA1ISCN10ASCN2A
SCHEMBL4563131 0.82 MAPT (0.40) CACNA1GCACNA1HCACNA1ISMN1; SMN2HTT
SCHEMBL5668410 0.81 LTA4H (0.48) CACNA1GCACNA1HCACNA1ISMN1; SMN2LMNA
SCHEMBL4386435 0.80 CACNA1G (0.43) CACNA1GCACNA1HCACNA1ITAOK1TAOK3
SCHEMBL4394082 0.80 CACNA1G (0.43) CACNA1GCACNA1HCACNA1ITAOK1TAOK3
SCHEMBL2172285 0.80 CACNA1G (0.45) CACNA1GCACNA1HCACNA1ISCN10ASMN1; SMN2
SCHEMBL4384719 0.78 TAOK1 (0.51) CACNA1GCACNA1HCACNA1ITAOK1TAOK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730128-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-12-13 EP claimed
WO-2005097765-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-10-20 WO claimed